Literature DB >> 29740891

Effects of gut microbiota and time of treatment on tissue levels of green tea polyphenols in mice.

Anna B Liu1, Siyao Tao1,2, Mao-Jung Lee1, Qi Hu1,2, Xiaofeng Meng1, Yong Lin3,4, Chung S Yang1,4.   

Abstract

The previous studies have shown that tea polyphenols are metabolized by gut microbiota. This study investigated the effect of gut microbiota on the bioavailability, tissue levels, and degradation of tea polyphenols. Mice were treated with antibiotics (ampicillin/sulfamethoxazole/trimethoprim) in drinking water and the control mice received water for 11 days, and they were given an AIN93M diet enriched with 0.32% of Polyphenon E. The levels of catechins and their metabolites (if present) in the serum, liver, urine, and fecal samples were determined by high-performance liquid chromatography. The results showed that treatment with antibiotics significantly increased the levels of the major polyphenol, (-)-epigallocatechin-3-gallate (EGCG), in serum and liver samples. Antibiotics also raised the levels of some catechins in urine and fecal samples but decreased the levels of their metabolites. These results suggest that antibiotics eliminated gut microbes and increased the bioavailabilities of these tea catechins. In a second study, mice were given different concentrations of green tea infusions as the drinking fluid. The plasma levels of EGCG and (-)-epicatechin-3-gallate (ECG) at day 112 were significantly lower than those at day 5. The urine levels of EGCG and ECG increased in the first 4 or 5 days, and then decreased to much lower levels at day 23 and beyond. In contrast, the levels of (-)-epigallocatechin and (-)-epicatechin showed a trend of increase during the 112-day experiment, likely owing to microbial hydrolysis of EGCG and ECG. Both sets of experiments support the idea that the degradation of EGCG and ECG by gut microbiota decreases their bioavailabilities.
© 2018 BioFactors, 2018. © 2018 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  antibiotics; bioavailability; gut microbiota; tea catechins

Year:  2018        PMID: 29740891      PMCID: PMC6222019          DOI: 10.1002/biof.1430

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  35 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

Review 2.  Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols.

Authors:  Michael N Clifford; Justin J J van der Hooft; Alan Crozier
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

3.  Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria.

Authors:  M R Meselhy; N Nakamura; M Hattori
Journal:  Chem Pharm Bull (Tokyo)       Date:  1997-05       Impact factor: 1.645

4.  Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species.

Authors:  Jong-Sik Jin; Mutsumi Touyama; Takayoshi Hisada; Yoshimi Benno
Journal:  Microbiol Immunol       Date:  2012-11       Impact factor: 1.955

Review 5.  The chemistry and biotransformation of tea constituents.

Authors:  Shengmin Sang; Joshua D Lambert; Chi-Tang Ho; Chung S Yang
Journal:  Pharmacol Res       Date:  2011-03-01       Impact factor: 7.658

6.  Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition.

Authors:  Shengmin Sang; Mao-Jung Lee; Ill Yang; Brian Buckley; Chung S Yang
Journal:  Rapid Commun Mass Spectrom       Date:  2008-05       Impact factor: 2.419

7.  Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans.

Authors:  Angélique Stalmach; Stéphanie Troufflard; Mauro Serafini; Alan Crozier
Journal:  Mol Nutr Food Res       Date:  2009-05       Impact factor: 5.914

Review 8.  Prevention of chronic diseases by tea: possible mechanisms and human relevance.

Authors:  Chung S Yang; Jungil Hong
Journal:  Annu Rev Nutr       Date:  2013-04-29       Impact factor: 11.848

9.  RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice.

Authors:  Felcy Pavithra Selwyn; Julia Yue Cui; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2015-05-08       Impact factor: 3.922

10.  Long-Term Green Tea Supplementation Does Not Change the Human Gut Microbiota.

Authors:  Pilou L H R Janssens; John Penders; Rick Hursel; Andries E Budding; Paul H M Savelkoul; Margriet S Westerterp-Plantenga
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

View more
  12 in total

Review 1.  Green Tea and Its Relation to Human Gut Microbiome.

Authors:  Sergio Pérez-Burillo; Beatriz Navajas-Porras; Alicia López-Maldonado; Daniel Hinojosa-Nogueira; Silvia Pastoriza; José Ángel Rufián-Henares
Journal:  Molecules       Date:  2021-06-26       Impact factor: 4.411

2.  Colon Bioaccessibility and Antioxidant Activity of White, Green and Black Tea Polyphenols Extract after In Vitro Simulated Gastrointestinal Digestion.

Authors:  Giuseppe Annunziata; Maria Maisto; Connie Schisano; Roberto Ciampaglia; Patricia Daliu; Viviana Narciso; Gian Carlo Tenore; Ettore Novellino
Journal:  Nutrients       Date:  2018-11-08       Impact factor: 5.717

3.  Effect of β-Glucan and Black Tea in a Functional Bread on Short Chain Fatty Acid Production by the Gut Microbiota in a Gut Digestion/Fermentation Model.

Authors:  Abbe M Mhd Jalil; Emilie Combet; Christine A Edwards; Ada L Garcia
Journal:  Int J Environ Res Public Health       Date:  2019-01-15       Impact factor: 3.390

Review 4.  Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives.

Authors:  Sabrina Bimonte; Vittorio Albino; Mauro Piccirillo; Aurelio Nasto; Carlo Molino; Raffaele Palaia; Marco Cascella
Journal:  Drug Des Devel Ther       Date:  2019-02-12       Impact factor: 4.162

5.  Urinary Metabolites of Green Tea as Potential Markers of Colonization Resistance to Pathogenic Gut Bacteria in Mice.

Authors:  Mark E Obrenovich; George E Jaskiw; Thriveen Sankar Chittoor Mana; Christina P Bennett; Jennifer Cadnum; Curtis J Donskey
Journal:  Pathog Immun       Date:  2019-11-14

6.  Fermentation of Foods and Beverages as a Tool for Increasing Availability of Bioactive Compounds. Focus on Short-Chain Fatty Acids.

Authors:  Giuseppe Annunziata; Angela Arnone; Roberto Ciampaglia; Gian Carlo Tenore; Ettore Novellino
Journal:  Foods       Date:  2020-07-25

7.  Epigallocatechin Gallate Can Protect Mice From Acute Stress Induced by LPS While Stabilizing Gut Microbes and Serum Metabolites Levels.

Authors:  Yong Ma; Gang Liu; Muyang Tang; Jun Fang; Hongmei Jiang
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

Review 8.  The Neuroprotective Effect of Tea Polyphenols on the Regulation of Intestinal Flora.

Authors:  Zhicheng Zhang; Yuting Zhang; Junmin Li; Chengxin Fu; Xin Zhang
Journal:  Molecules       Date:  2021-06-17       Impact factor: 4.411

9.  Anti-Influenza with Green Tea Catechins: A Systematic Review and Meta-Analysis.

Authors:  Anchalee Rawangkan; Kirati Kengkla; Sukrit Kanchanasurakit; Acharaporn Duangjai; Surasak Saokaew
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

Review 10.  Gut/Oral Bacteria Variability May Explain the High Efficacy of Green Tea in Rodent Tumor Inhibition and Its Absence in Humans.

Authors:  Guy R Adami; Christy Tangney; Joel L Schwartz; Kim Chi Dang
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.